LACEE OSTEEN: Open Payments
NPI 1255087409 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$84 in 5 payments from 5 companies in 2025. Trend: 2023 $39 · 2024 $167 · 2025 $84
Food & beverage: $84
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 1 | $20 |
| Organon LLC | 1 | $20 |
| Sage Therapeutics, LLC | 1 | $15 |
| Supernus Pharmaceuticals, Inc. | 1 | $15 |
| MILLICENT US INC | 1 | $14 |
Products named: Dexcom G6 Transmitter, NEXPLANON, ZURZUVAE, Qelbree, FEMLYV.
Industry payments across TX — which companies pay providers there.
